Uncoupling Protein 2 Promoter Polymorphism - 866G/A Affects Its Expression in β-Cells and Modulates Clinical Profiles of Japanese Type 2 Diabetic Patients

Diabetes

Volumn 53, Issue 2, 2004, Pages 482-485

  Sasahara, Miyoshi ^a   Nishi, Masahiro ^a   Kawashima, Hiromichi ^a   Ueda, Kazuya ^a   Sakagashira, Setsuya ^a   Furuta, Hiroto ^a   Matsumoto, Eisaku ^a   Hanabusa, Tadashi ^a   Sasaki, Hideyuki ^a   Nanjo, Kishio ^a  

^a WAKAYAMA MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN; UNCOUPLING PROTEIN 2;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENETIC POLYMORPHISM; HUMAN; INSULIN RELEASE; JAPAN; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; PROMOTER REGION;

AGED; ASIAN CONTINENTAL ANCESTRY GROUP; BASE SEQUENCE; DIABETES MELLITUS; DIABETES MELLITUS, TYPE 2; DNA PRIMERS; FEMALE; GENOTYPE; HUMANS; ION CHANNELS; ISLETS OF LANGERHANS; JAPAN; MALE; MEMBRANE TRANSPORT PROTEINS; MITOCHONDRIAL PROTEINS; OBESITY; POLYMORPHISM, SINGLE NUCLEOTIDE; REFERENCE VALUES;

EID: 10744222893     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.53.2.482     Document Type: Article

References (17)

1. Kahn SE: The relative contributions of insulin resistance and beta-cell dysfunction to the pathophysiology of type 2 diabetes. Diabetologia 46:3-19, 2003
2. Lee ET, Keen H, Bennett PH, Fuller JH, Lu M, WHO Multinational Study Group: Follow-up of the WHO multinational study of vascular disease in diabetes: general description and morbidity. Diabetologia 44 (Suppl. 2):S3-S13, 2001
3. Matsumoto K, Miyake S, Yano M, Ueki Y, Yamaguchi Y, Akazawa S, Tominaga Y: Glucose tolerance, insulin secretion, and insulin sensitivity in nonobese and obese Japanese subjects. Diabetes Care 20:1562-1568, 1997
4. DeFronzo RA: Pathogenesis of type 2 (non-insulin dependent) diabetes mellitus: a balanced overview. Diabetologia 35:389-397, 1992
5. Saleh MC, Wheeler MB, Chan CB: Uncoupling protein-2: evidence for its function as a metabolic regulator. Diabetologia 45:174-187, 2002
6. Zhang CY, Baffy G, Perret P, Krauss S, Peroni O, Grujic D, Hagen T, Vidal-Puig J, Boss O, Kim YB, Zheng XX, Wheeler MB, Schulman GI, Chan CB: Uncoupling protein-2 negatively regulates insulin secretion and is a major link between obesity, β cell dysfunction, and type 2 diabetes. Cell 105:745-755, 2001
7. Joseph JW, Koshkin V, Zhang CY, Wang J, Lowell BB, Chan CB, Wheeler MB: Uncoupling protein 2 knockout mice have enhanced insulin secretary capacity after a high-fat diet. Diabetes 51:3211-3219, 2002
8. Chan CB, De Leo D, Joseph JW, McQuaid TS, Ha XF, Xu F, Tsushima RG, Pennefather PS, Salapatek AM, Wheeler MB: Increased uncoupling protein-2 levels in β-cells are associated with impaired glucose-stimulated insulin secretion: mechanism of action. Diabetes 50:1302-1310, 2001
9. Lameloise N, Muzzin P, Prentki M, Assimacopoulos-Jeannet F: Uncoupling protein 2: a possible link between fatty acid excess and impaired glucose-induced insulin secretion? Diabetes 50:803-809, 2001
10. Esterbauer H, Schneitler C, Oberkofler H, Ebenbichler C, Paulweber B, Sandhofer F, Ladurner G, Hell E, Strosberg AD, Patsch JR, Krempler F, Patsch W: A common polymorphism in the promoter of UCP2 is associated with decreased risk of obesity in middle-aged humans. Nat Genet 28:178-183, 2001
11. The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus: Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 21 (Suppl. 1):S5-S19, 1998
12. Yamasaki Y, Kodama M, Nishizawa H, Sakamoto K, Matsuhisa M, Kajimoto Y, Kosugi K, Shimizu Y, Kawamori R, Hori M: Carotid intima-media thickness in Japanese type 2 diabetic subjects: predictors of progression and relationship with incident coronary heart disease. Diabetes Care 23:1310-1315, 2000
13. Yan YJ, Youn JH, Bergman RN: Modified protocols improve insulin sensitivity estimation using the minimal model. Am J Physiol 253:E595-E602, 1987
14. Asfari M, Janjic D, Meda P, Li G, Halban PA, Wolheim CB: Establishment of 2-mercaptoethanol-dependent differentiated insulin-secreting cell lines. Endocrinology 130:167-178, 1992
15. Krempler F, Esterbauer H, Weitgasser R, Ebenbichler C, Patsch JR, Miller K, Xie M, Linnemayr V, Oberkofler H, Patsch W: A functional polymorphism in the promoter of UCP2 enhances obesity risk but reduces type 2 diabetes risk in obese middle-aged humans. Diabetes 51:3331-3335, 2002
16. Antinozzi PA, Ishihara H, Newgard CB, Wollheim CB: Mitochondrial metabolism sets the maximal limit of fuel-stimulated insulin secretion in a model pancreatic beta cell: a survey of four fuel secretagogues. J Biol Chem 277:11746-11755, 2002
17. Sesti G, Cardellini M, Marini MA, Frontoni S, D'Adamo M, Del Guerra S, Lauro D, De Nicolais P, Sbraccia P, Del Prato S, Gambardella S, Federici M, Marchetti P, Lauro R: A common polymorphism in the promoter of UCP2 contributes to the variation in insulin secretion in glucose-tolerant subjects. Diabetes 52:1280-1283, 2003